Human intestine and liver microsomal metabolic differences between C19-diester and monoester diterpenoid alkaloids from the roots of Aconitum carmichaelii Debx.

Toxicology in Vitro - Tập 45 - Trang 318-333 - 2017
Min Zhang1, Chong-sheng Peng1, Xiao-bo Li1
1School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China

Tài liệu tham khảo

Ameri, 1998, The effects of Aconitum alkaloids on the central nervous system, Prog. Neurobiol., 56, 211, 10.1016/S0301-0082(98)00037-9 Bi, 2013, Metabolites and metabolic pathways of mesaconitine in rat liver microsomal investigated by using UPLC-MS/MS method in vitro, Acta Pharm. Sin., 48, 1823 Bi, 2013, Analysis of hypaconitine's metabolites and related metabolic CYP isoforms in rat liver microsomal by UPLC-MS/MS, J. Chin. Mass Spec. Soc., 34, 330 Chan, 2009, Aconite poisoning presenting as hypotension and bradycardia, Hum. Exp. Toxicol., 28, 795, 10.1177/0960327109353056 Chan, 2009, Aconite poisoning, Clin. Toxicol., 47, 279, 10.1080/15563650902904407 Chen, 2010, Analysis on the metabolites of mesaconitine in the rat urine by liquid chromatography and electrospray ionization mass spectrometry, Acta Pharm. Sin., 45, 1043 Chinese Pharmacopoeia Commission, 2010, 36 Galetin, 2008, Potential role of intestinal first-pass metabolism in the prediction of drug-drug interactions, Expert Opin. Drug Metab. Toxicol., 4, 909, 10.1517/17425255.4.7.909 Hu, 2009, Structural characterization and identification of C19- and C-20 diterpenoid alkaloids in roots of Aconitum carmichaeli by rapid-resolution LC coupled with TOF MS, Rapid Commun. Mass Spectrom., 23, 1619, 10.1002/rcm.4038 Jian, 2012, Structure-cardiac activity relationship of C19-diterpenoid alkaloids, Nat. Prod. Commun., 7, 713 Komura, 2011, In vitro and in vivo small intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences, Drug Metab. Rev., 43, 476, 10.3109/03602532.2011.597401 Li, 2000, Advance in research of drug phase II metabolisms and conjugation enzymes, Chin. J. Clin. Pharmacol., 16, 458 Masi, 2009, Nuclear receptors CAR and PXR: molecular, functional, and biomedical aspects, Mol. Asp. Med., 30, 297, 10.1016/j.mam.2009.04.002 Pfeiffer, 2006, Microsomal hydroxylation and glucuronidation of [6]-gingerol, J. Agric. Food Chem., 54, 8769, 10.1021/jf062235l Silva, 2003, Glucuronidation patterns of common urinary and serum monoester phthalate metabolites, Arch. Toxicol., 77, 561, 10.1007/s00204-003-0486-3 Singhuber, 2009, Aconitum in traditional Chinese medicine—a valuable drug or an unpredictable risk?, J. Ethnopharmacol., 126, 18, 10.1016/j.jep.2009.07.031 Tang, 2011, Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes, Toxicol. Lett., 202, 47, 10.1016/j.toxlet.2011.01.019 Wang, 2002, Electrospray ionization tandem mass spectrometric study of the aconitines in the roots of aconite, Rapid Commun. Mass Spectrom., 16, 2075, 10.1002/rcm.828 Wang, 2006, Characterization of metabolites and cytochrome P450 isoforms involved in the microsomal metabolism of aconitine, J. Chromatogr. B, 844, 292, 10.1016/j.jchromb.2006.07.059 Ye, 2011, Microsomal cytochrome P450-mediated metabolism of hypaconitine, an active and highly toxic constituent derived from Aconitum species, Toxicol. Lett., 204, 81, 10.1016/j.toxlet.2011.04.015 Ye, 2011, Characterization of metabolites and human P450 isoforms involved in the microsomal metabolism of mesaconitine, Xenobiotica, 41, 46, 10.3109/00498254.2010.524950 Ye, 2013, The role of efflux transport of highly toxic aconitine, mesaconitine, hypaconitine, and therir hydroysates, as determined in cultured Caco-2 and transfected MDCKII cells, Toxicol. Lett., 216, 86, 10.1016/j.toxlet.2012.11.011 Ye Zhang, 2015 Zhao, 2008, Studies on the biotransformation of 16-O-demethylaconitine and electrospray ionization tandem mass spectrometry, Acta Chim. Sin., 66, 525 Zhou, 1984, The toxicity of aconitine and its analogs and their effects on cardiac contractile function, Acta Pharm. Sin., 19, 641